Internal Medicine, Rheumatology · Hickory, NC
NPI
1922190255
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
225 18th St SE
Hickory, NC, 28602
Phone (828) 322-1996
Groups this clinician bills Medicare through
Medicare paid, 2024
$531K
64,469 services
Medicare patients, 2024
237
Average age 72
Drug cost, 2024
$2.6M
4,385 prescriptions
Company payments, 2025
$1,394
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jill A McClory was code J1602 (injection, golimumab, 1 mg, for intravenous use), 8,300 times for 11 patients. In total Jill A McClory billed 64,469 services in 28 codes, and Medicare paid $531K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 8,300 | 11 | $9.06 | $75K |
| J0897 Injection, denosumab, 1 mg | Office | 1,620 | 16 | $19.80 | $32K |
| 99214 Office E&M - Established | Office | 393 | 197 | $83.29 | $33K |
| 96372 Injection Administration | Office | 234 | 27 | $10.71 | $2,506 |
| 96413 Chemotherapy Administration | Office | 118 | 21 | $90.95 | $11K |
| 99204 Office E&M - New | Office | 51 | 51 | $114.40 | $5,835 |
| 99213 Office E&M - Established | Office | 42 | 36 | $56.27 | $2,363 |
By year: 2022 $617K for 52,941 services; 2023 $566K for 60,519 services; 2024 $531K for 64,469 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jill A McClory prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 637 prescriptions and refills. In total Jill A McClory wrote 4,385 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 637 | 1,098 | 123 | $19K |
| Prednisone Generic | 623 | 793 | 157 | $3,454 |
| Methotrexate Methotrexate Sodium | 529 | 966 | 106 | $10K |
| Leflunomide Generic | 262 | 447 | 53 | $14K |
| Tramadol Hcl Generic | 219 | 219 | 31 | $1,187 |
| Diclofenac Sodium Generic | 139 | 171 | 36 | $2,197 |
| Tizanidine Hcl Generic | 134 | 202 | 30 | $962 |
| Gabapentin Generic | 133 | 215 | 27 | $1,820 |
| Alendronate Sodium Generic | 131 | 242 | 26 | $934 |
| Allopurinol Generic | 130 | 236 | 26 | $838 |
| Celecoxib Generic | 111 | 149 | 21 | $1,212 |
| Pregabalin Generic | 109 | 143 | 19 | $2,643 |
| Duloxetine Hcl Generic | 104 | 178 | 19 | $1,386 |
| Humira(Cf) Pen Adalimumab | 83 | 83 | Under 11 | $677K |
| Cyclobenzaprine Hcl Generic | 81 | 103 | 14 | $905 |
Brand drugs: - claims; generic drugs: 3,931 claims; opioid claims: 242.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jill A McClory $1,394 ($1,394 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $226.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 19 | $226 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $180 |
| UCB, Inc. UCB.BR | 12 | $166 |
| Abbvie Inc. ABBV | 12 | $159 |
| Janssen Biotech, Inc. JNJ | 10 | $156 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $87.31 |
| Pfizer Inc. PFE | 4 | $83.97 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $67.73 |
| Radius Health, Inc. | 3 | $66.04 |
| GlaxoSmithKline, LLC. GSK | 3 | $65.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.